Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on October 30, 2018. The report addresses a corporate governance event under Item 8.01 (Other Events) regarding a senior executive appointment.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Kevin M. Barry as the new Chief Legal Officer, Corporate Secretary, and Chief Compliance Officer. This appointment is effective November 5, 2018.
Guidance, Outlook, and Management Commentary
Mr. Barry joins the Company from BioFire Diagnostics, a bioMerieux company, where he served as Vice President of Legal Affairs and Chief Compliance Officer. His prior experience includes senior legal roles at Sonova Group, CareFusion, and Cardinal Health. The filing contains no financial guidance, risk factors, or contingencies.
Key Facts for Investor Verification
- Kevin M. Barry is appointed to three roles: Chief Legal Officer, Corporate Secretary, and Chief Compliance Officer.
- The effective date of the appointment is November 5, 2018.
- The appointment was announced on October 30, 2018.
- The report does not disclose any financial results or operational metrics.